UBS Group’s Hoth Therapeutics HOTH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $49.4K | Sell |
42,240
-16,518
| -28% | -$19.3K | ﹤0.01% | 6499 |
|
2025
Q1 | $58.8K | Buy |
58,758
+27,765
| +90% | +$27.8K | ﹤0.01% | 6171 |
|
2024
Q4 | $23.2K | Sell |
30,993
-25,471
| -45% | -$19.1K | ﹤0.01% | 6553 |
|
2024
Q3 | $49.7K | Buy |
56,464
+13,109
| +30% | +$11.5K | ﹤0.01% | 5628 |
|
2024
Q2 | $39.4K | Buy |
43,355
+41,205
| +1,917% | +$37.5K | ﹤0.01% | 5723 |
|
2024
Q1 | $3.27K | Sell |
2,150
-6,297
| -75% | -$9.57K | ﹤0.01% | 6579 |
|
2023
Q4 | $12.2K | Buy |
8,447
+4,297
| +104% | +$6.19K | ﹤0.01% | 6158 |
|
2023
Q3 | $6.31K | Sell |
4,150
-144
| -3% | -$219 | ﹤0.01% | 6170 |
|
2023
Q2 | $12.9K | Sell |
4,294
-4,534
| -51% | -$13.6K | ﹤0.01% | 5983 |
|
2023
Q1 | $18.2K | Buy |
8,828
+4,849
| +122% | +$9.99K | ﹤0.01% | 6057 |
|
2022
Q4 | $31K | Buy |
3,979
+3,817
| +2,356% | +$29.8K | ﹤0.01% | 6042 |
|
2022
Q3 | $1K | Sell |
162
-74
| -31% | -$457 | ﹤0.01% | 8855 |
|
2022
Q2 | $2K | Sell |
236
-182
| -44% | -$1.54K | ﹤0.01% | 8515 |
|
2022
Q1 | $7K | Buy |
+418
| New | +$7K | ﹤0.01% | 7762 |
|
2021
Q4 | – | Sell |
-39
| Closed | -$1K | – | 9221 |
|
2021
Q3 | $1K | Buy |
+39
| New | +$1K | ﹤0.01% | 8030 |
|
2021
Q2 | – | Sell |
-216
| Closed | -$11K | – | 8385 |
|
2021
Q1 | $11K | Buy |
216
+30
| +16% | +$1.53K | ﹤0.01% | 6831 |
|
2020
Q4 | $11K | Buy |
+186
| New | +$11K | ﹤0.01% | 6383 |
|
2020
Q3 | – | Sell |
-24
| Closed | -$2K | – | 7217 |
|
2020
Q2 | $2K | Buy |
24
+3
| +14% | +$250 | ﹤0.01% | 6769 |
|
2020
Q1 | $2K | Sell |
21
-61
| -74% | -$5.81K | ﹤0.01% | 6690 |
|
2019
Q4 | $13K | Buy |
82
+70
| +583% | +$11.1K | ﹤0.01% | 6068 |
|
2019
Q3 | $1K | Sell |
12
-79
| -87% | -$6.58K | ﹤0.01% | 6863 |
|
2019
Q2 | $13K | Buy |
91
+83
| +1,038% | +$11.9K | ﹤0.01% | 6015 |
|
2019
Q1 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 6704 |
|